ملخص
Tubulocystic carcinoma of the kidney (TC-RCC) is a rare renal tumor and has been recently included as a distinct entity in WHO classification of renal neoplasms. We report the case of a patient with metastatic tubulocystic RCC whose disease progressed through standard of care treatment for nonclear RCC. However, genetic analysis revealed a germline pathogenic variant of fumarate hydratase (FH) gene, and the patient had a sustained and durable response to pazopanib.
اللغة الأصلية | English |
---|---|
الصفحات (من إلى) | 240-248 |
عدد الصفحات | 9 |
دورية | Case Reports in Oncology |
مستوى الصوت | 16 |
رقم الإصدار | 1 |
المعرِّفات الرقمية للأشياء | |
حالة النشر | Published - أبريل 14 2023 |
ASJC Scopus subject areas
- ???subjectarea.asjc.2700.2730???